
New early detection sensor for type 1 diabetes
Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease.
Researchers are developing early detection technology for Type 1 diabetes that can accurately predict if a child is at risk of the chronic disease.
Data scientists have used deep learning to identify the right synergistic drug combinations for the rapidly spreading SARS-CoV-2.
Studying these organoids could help researchers develop and test new treatments for pancreatic cancer.
The MasSpec Pen has shown to accurately differentiate healthy and cancerous tissue from banked pancreas samples during surgery.
A convection-enhanced macroencapsulation device offers the potential of faster and more effective treatment for people with type 1 diabetes.
A research program explores the use of mixed reality for enabling surgeons to identify brain tumors quickly and precisely.
Tests show that the device can help patients safely and effectively manage their blood glucose levels and reduce the risk of low blood sugar levels.
Bioengineers are using 3D printing and smart biomaterials to create an insulin-producing implant for type 1 diabetes patients.
This overview introduces smart insulin delivery systems and more innovations that help patients and doctors guide decision-making in diabetes care.
An organoid on chip platform mimics robustly key features of human pancreas development. This is a stepping stone towards reliable diagnostic solutions for early-stage pancreatic cancer.
The MasSpec Pen has shown to accurately identify tissues and surgical margins directly in patients and differentiate healthy and cancerous tissue from banked pancreas samples.
Scientists at Utrecht University have published a first consensus on what is and what is not an organoid.
Scientists have found that a simple device can reduce swelling after kidney transplantation. Clinical trial shows shortened hospital stay for patients and reduced surgical site infections by almost 60 percent.
Researchers have experimentally demonstrated a novel cancer diagnosis technique based on the scattering of circularly polarized light.
EPFL spin-off Readily3D has developed a novel system that can print biological tissue in just 30 seconds.
Researchers have developed a 3D printed ingestable capsule that can capture samples throughout the gut and safely transport these outside the body for testing.
Researchers have developed a neural network capable of recognizing retinal tissues during the process of their differentiation in a dish.
For the first time, researchers managed to make intact human organs transparent. Using microscopic imaging they could revealed underlying complex structures of the see-through organs at the cellular level.
Researchers have developed a smart insulin-delivery patch that could one day monitor and manage glucose levels in people with diabetes and deliver the necessary insulin dosage.
Researchers found that using 3D models to prepare for kidney tumor surgeries resulted in substantial improvements, including shorter operating times.
Scientists have now developed guidelines that should enable the safe development of nanoparticles for medical use.
A scientist is working to develop miniature implantable medical devices that sense and communicate wirelessly via sound waves.
Pancreas-on-a-chip allowes scientists to identify the possible cause of a frequent and deadly complication of cystic fibrosis called CF-Related Diabetes, or CFRD.
Fitness trackers can be valuable tools for assessing the quality of life and daily functioning of cancer patients during treatment, a new study has found.
MIT engineers have developed new technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans.